KRAIG BIOCRAFT LABORATORIES, INC. Amortization of Debt Issuance Costs
KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Amortization of Debt Issuance Costs of $1.11 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-04-01
- KRAIG BIOCRAFT LABORATORIES, INC. amortization of debt issuance costs for the quarter ending 2022-12-31 was $398.60K, a 24.79% decline year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. amortization of debt issuance costs for the quarter ending 2022-09-30 was $176.28K, a 91.56% decline year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. amortization of debt issuance costs for the quarter ending 2022-06-30 was $174.67K, a 90.55% decline year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. amortization of debt issuance costs for the quarter ending 2022-03-31 was $362.03K, a 53.73% increase year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. amortization of debt issuance costs for fiscal 2022 was $1.11M, a 76.36% decline from fiscal 2021.
- KRAIG BIOCRAFT LABORATORIES, INC. amortization of debt issuance costs for fiscal 2021 was $4.70M, a 9211.79% increase from fiscal 2020.
- KRAIG BIOCRAFT LABORATORIES, INC. amortization of debt issuance costs for fiscal 2020 was $50.51K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $398.60K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $574.88K derived: sum of 2 quarters · filed 2024-04-01 | $749.55K derived: sum of 3 quarters · filed 2024-04-01 | $1.11M 10-K · filed 2024-04-01 |
| 2022-09-30 | $176.28K 10-Q · filed 2023-11-13 | $350.94K derived: sum of 2 quarters · filed 2023-11-13 | $712.98K 10-Q · filed 2023-11-13 | $1.24M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $174.67K 10-Q · filed 2023-08-14 | $536.70K 10-Q · filed 2023-08-14 | $1.07M derived: sum of 3 quarters · filed 2023-08-14 | $3.16M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $362.03K 10-Q · filed 2023-05-12 | $892.00K derived: sum of 2 quarters · filed 2023-05-12 | $2.98M derived: sum of 3 quarters · filed 2023-05-12 | $4.83M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $529.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $2.62M derived: sum of 2 quarters · filed 2023-03-29 | $4.47M derived: sum of 3 quarters · filed 2023-03-29 | $4.70M 10-K · filed 2023-03-29 |
| 2021-09-30 | $2.09M 10-Q · filed 2022-11-14 | $3.94M derived: sum of 2 quarters · filed 2022-11-14 | $4.17M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.85M 10-Q · filed 2022-08-01 | $2.08M 10-Q · filed 2022-08-01 | ||
| 2021-03-31 | $235.49K 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $50.51K 10-K · filed 2022-03-16 |